Ajinomoto North America, Inc.'s Milk Protein-Derived Nutraceutical Solution is a Safeguard for Healthy Blood Pressure

With Natura Guard BP™, Health-Vigilant Americans Can Maintain Blood Pressure Levels Already Within the Normal Range*

Nov 14, 2011, 10:46 ET from Ajinomoto North America, Inc.

FORT LEE, N.J., Nov. 14, 2011 /PRNewswire/ -- Ajinomoto North America, Inc., a leader in the development of pharmaceutical-quality amino acids and safe, effective nutraceutical solutions, has introduced Natura Guard BP™, a milk protein-derived supplement, to help health-conscious Americans maintain healthy blood pressure levels that are already within the normal range*.   The efficacy and safety of Natura Guard BP™ in which a dietary ingredient, lactotripeptides, works by inhibiting an enzyme that contributes to blood vessel constriction or tightening has been proven in more than 20 published clinical studies.

According to the Centers for Disease Control and Prevention (CDC), favorable blood pressure levels are associated with a greater probability of living longer and without major health issues(1).  Keeping up with blood pressure health also makes good financial sense:  In 2010, high blood pressure cost the United States over $76 billion in healthcare services, medications, and missed days of work(2).

"Maintaining healthy blood pressure should be an important goal of anyone concerned with their overall good health and longevity," said Jeremy A. Holt, Manager, Health Ingredients and Services, Ajinomoto North America, Inc.  "This is even more critical in today's economy, when health concerns and issues can quickly become a drain on financial and other resources."

Clinical studies of Natura Guard BP™'s ingredient have demonstrated significant changes in both systolic and diastolic blood pressure(3).  "Ajinomoto Group's competitive advantage lies in our extensive clinical data," said Mr. Holt.  "All of the research shows that Natura Guard BP™ offers a safe, effective and side effect-free solution to maintaining healthy blood pressure."  In addition to 20 published, placebo-controlled studies, Natura Guard BP™'s body of research includes a meta-analysis.    

Natura Guard BP™'s dietary ingredient consists of two tripeptides naturally derived from the milk protein casein.  Effective after three to four weeks of daily use, Natura Guard BP™ has no rebound effect.  

In addition to Natura Guard BP™, Ajinomoto North America, Inc. makes Capsiate Natura®, a patented, side effect-free dietary supplement with natural capsinoids shown to boost the body's metabolism*  and Glysom™, a safe, effective and scientifically-proven amino acid-based solution for deeper, sounder and more satisfying sleep*.  Ajinomoto North America, Inc. will next showcase its trio of nutraceutical products at ACAM's Exchange 2011 in Portland, Oregon, November 16-20, 2011.  

Natura Guard BP™, Capsiate Natura® and Glysom™ are available exclusively through medical professionals.  For more information and a complete list of healthcare professionals that carry Ajinomoto North America's nutraceuticals, visit www.capsiatenatura.com, www.glysom.com and www.naturaguardbp.com.

Natura Guard BP™ clinical studies are available on request.

About Ajinomoto North America, Inc.

Ajinomoto North America, Inc delivers safe, effective ingredients whose functionality has been scientifically proven.  Our mission is the pursuit of better health through better nutrition.  Beginning with AJI-NO-MOTO® MSG, a highly versatile seasoning, our products have diversified to flavor seasonings (bonito, pork, chicken, and beef), sweeteners, savory sauces, enzymes, other food ingredients and nutritional supplements.  Based on the five basic tastes centering on Umami, Ajinomoto supplies ingredients with unique aroma, texture, kokumi (full-bodied taste) and nutritional functionality.  These ingredients make it possible for our customers to build strong brands and offer consumers great-tasting, nutritionally beneficial products.

(1) Ostchega Y, Yoon SS, Hughes J, Louis T. Hypertension awareness, treatment, and control—continued disparities in adults: United States. Centers for Disease Control. No. 3 (2008): 1-8

(2) Lloyd-Jones D, Adams RJ, Brown TM, et al. Heart Disease and Stroke Statistics—2010 Update. A Report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation (2010): 1-170

(3) Y., Nakamura. et. al. J. Nutr Food., 7(1), 123-137. 2004

*These statements have not been evaluated by the Food and Drug Administration.
This product is not intended to diagnose, treat, cure, or prevent any disease.

SOURCE Ajinomoto North America, Inc.